BRCA2 and ovarian cancer: Since then, the screening of BRCA1 and BRCA2 has been performed in multiple populations across the world revealing that 10 to 50% of breast cancer patients with family history of breast and/or ovarian cancer carry a BRCA1 or BRCA2 mutation [3].